Background {#Sec1}
==========

Diarrheal disease is a leading cause of pediatric morbidity and mortality in developing countries \[[@CR1],[@CR2]\], and it is associated with a significant burden in industrialized countries.

The etiology of diarrhea has been studied in both developed \[[@CR3]-[@CR5]\] and developing countries \[[@CR2],[@CR6]-[@CR8]\], and it was shown that enteropathogens implicated in the etiology of diarrhea may vary among regions and populations, even when the same epidemiological and microbilogical methods are utilized \[[@CR2]\].

Among the major recent advances in molecular diagnosis of enteropathogens is the ability to distinguish between *Escherichia coli* of the normal microbiota and diarrheagenic *E. coli* strains, based on the characterization of virulence genes with polymerase chain reaction (PCR) \[[@CR9]\]. Diarrheagenic *E. coli* (DEC) includes different pathotypes of *E. coli* that can induce diarrhea, and are mainly sub-grouped into: enteroaggregative *E. coli* (EAEC), enterohemorrhagic *E. coli* (EHEC) which belongs to the Shiga toxin-producing *E. coli*, typical and atypical enteropathogenic *E. coli* (EPEC) characterized by encoding the bundle-forming pilus (bfp) (typical EPEC), and the enterotoxin-producing enterotoxigenic *E. coli* (ETEC) \[[@CR9],[@CR10]\]. Despite progress in the field of enteropathogen detection, utilization of PCR-based systems is typically limited to reference laboratories, mostly in the framework of outbreak investigations. Nonetheless, there is public health significance for monitoring and characterization of circulating DEC strains under non-epidemic conditions for rapid identification of emerging virulent strains with potential to cause epidemics such as the recent large-scale epidemic of DEC that occurred in 2011 in Germany, involving more than 3500 cases and 45 deaths \[[@CR11]\]. Currently the role of DECs in sporadic pediatric diarrhea in industrialized countries remains under-recognized. Therefore, we aimed to examine the presence of the 4 DEC categories (EAEC, EHEC, EPEC and ETEC) in stool samples obtained from children less than 5 years of age hospitalized for acute diarrhea in Israel and examine the association between mixed infection of DEC with other enteropathogens and clinical manifestation of disease.

Methods {#Sec2}
=======

Study design and population {#Sec3}
---------------------------

A prospective ongoing hospital-based diarrheal disease surveillance network was established in 2007 \[[@CR12]\]. The study targeted children less than 5 years of age living in the catchment area of 3 hospitals in Israel. Inclusion criteria included: hospitalization for diarrhea (3 or more watery stools per 24 hours), parents providing an informed consent, and collection of a stool sample. Children were enrolled all year round, and stool samples were obtained from patients within 24 hours of admission. Information about symptoms (e.g., number of loose/watery stools, vomiting, bloody stools, fever ≥39°C) was collected by parental interview and from medical records. Children were excluded from the study if their parents refused to participate. The study included 307 children hospitalized between 2007 and 2011, who had sporadic cases of diarrhea. Since the condition of these children required hospitalization, all were considered as severe diarrhea patients.

The study protocol was approved by the institutional review boards (IRBs) of the Hiller Yaffe, Carmel and Laniado medical centers and by the Ministry of Health. Parents signed written informed consent.

Stool samples (n = 188) were tested for rotavirus antigens by immunochromatography, and for *Shigella*, *Salmonella* and *Campylobacter* by standard stool culture at each hospital\'s laboratory. A portion of each specimen was sent in cool conditions to the research laboratory at Tel Aviv University where it was frozen at −80°C until plated on MacConkey and CHROMagar ECC plates for detection of *E. coli. E. coli* isolates were then shipped to Gothenburg University in Sweden for identification of the main DEC by mPCR.

Bacterial growth and preparation of DNA templates {#Sec4}
-------------------------------------------------

Up to three *E. coli* isolates from each child were cultured for over-night in LB broth at 37°C, and used for preparation of DNA for mPCR. A portion of the over-night culture from each examined bacterial strain was centrifuged and re-suspended by vortex in sterile deionized water. The bacterial suspension was then boiled at 100°C for 5 minutes then centrifuged at a Relative Centrifugal Force of 16,000 × *g* for 2 minutes. Aliquots of the supernatants were frozen at −20°C, and used as template for mPCR.

Multiplex PCR {#Sec5}
-------------

The mPCR was developed using specific control *E. coli* strains, or DNA from EHEC, as described previously \[[@CR13]\].

Additional microbiological tests were performed on EAEC, which was shown to be involved in diarrhea in other developed country settings.

Antimicrobial susceptibility {#Sec6}
----------------------------

Susceptibility of the EAEC isolates to amoxicillin/clavulanate (AMC), ampicillin (AMP), cefixime (CFM), ceftriaxone (CRO), cefuroxime (CXM), cepahlexin (CL), cephalothin (KF), chloramphenicol (C), ciprofloxacin (CIP), gentamicin (GM), nalidixic acid (NA), norfloxacin (NOR), sulfamethoxazole-trimethoprim (SXT) and tetracycline (T) was determined by the Kirby-Bauer disk diffusion method \[[@CR14]\]. The tests were carried out on the Müller-Hinton medium using Oxoid antimicrobial susceptibility disks (Oxoid, Hampshire, England; Becton, Dickinson and Company, Sparks MD, USA), and the interpretations were according to CLSI standards \[[@CR15]\].

O-typing of EAEC isolates {#Sec7}
-------------------------

All the identified EAEC isolates were serotyped by agglutination assays using 96-well microtiter plates and rabbit sera (SERUNAM) obtained against 187 somatic antigens and 53 flagellar antigens for *E. coli*, and against 45 somatic antigens for Shigella species \[[@CR16]\].

PFGE analysis {#Sec8}
-------------

Pulsed-field gel electrophoresis (PFGE) analysis was performed according to the PulseNet standardized PFGE protocol for *E. coli* using *Salmonella* serotype Braenderup strain H9812 as a marker. Agarose-embedded *E. coli* DNA was digested with XbaI (Fermentas) followed by gel electrophoresis in the CHEF MAPPER (Bio-Rad) system. Electrophoresis conditions were 14°C, 0.5×Tris-borate-EDTA buffer, initial pulse 2.2 s, final pulse 54.2 s, 6 V, 18 h. PFGE restriction patterns were analyzed by the BioNumerics software (Applied Maths). Pulsotypes were compared using the band-based DICE similarity coefficient with 1% optimization and tolerance. The un-weighted pair group method with arithmetic mean (UPGMA) algorithm was used for cluster analysis.

Statistical analysis {#Sec9}
--------------------

The prevalence of DECs and antibiotic resistant strains was presented using frequencies and percentages. The association between detection of enteropathogens and clinical symptoms (having more than 10 loose stools in the most severe day of illness, vomiting, or fever \>39°C) was examined using chi square test, and stepwise logistic regression model in which the outcome variable was having more than 10 loose stools on the most severe day of illness (1 = yes, 0 = no), and the explanatory variables in the first step were co-infection between EAEC and rotavirus, *Shigella*, *Salmonella*, and *Campylobacter*. Adjusted odds ratio (OR) and 95% confidence intervals (CIs) were obtained from the model. Two sided Pv \< 0.05 was considered significant.

Results {#Sec10}
=======

Distribution of DEC pathotypes among the *E. coli* isolates {#Sec11}
-----------------------------------------------------------

Isolates from 307 children were examined by mPCR, using specific primers as previously described \[[@CR12]\], of which 59 (19.2%) were positive for at least one of the four tested DEC. EAEC and atypical EPEC were the most common DEC, each detected in 27 children (46%). ETEC was found in 3 children, while EHEC and typical-EPEC were each found in one child. Co-infection with DEC and another enteric pathogen were common, as revealed by results of stools (n = 188) tested for all DECs, rotavirus and bacterial pathogens. Single infection with DEC was found in 9.5% of children (Table [1](#Tab1){ref-type="table"}).Table 1**Detection of enteric pathogens in stool specimens of diarrhea patientsNo. specimens** ^**\***^**%**Negative to all tested pathogens5529.3Rotavirus only6333.5*Salmonella* only31.6*Shigella* only126.4*Campylobacter* only73.7ETEC only00.0EHEC only10.5EAEC only73.7Atypical EPEC only94.8Typical EPEC only10.5Co-infectionsRotavirus & *Salmonella*31.6Rotavirus & *Campylobacter*42.1Rotavirus & ETEC21.1Rotavirus & EAEC94.8Rotavirus & atypical EPEC94.8*Shigella* & EAEC10.5*Campylobacter* & EAEC10.5*Campylobacter* & atypical EPEC10.5Total DEC in both single and co-infections4121.8Total samples tested188100.0^\*^This analysis is based on samples from 188 children who were tested for all pathogens presented in the table.

Clinical symptoms {#Sec12}
-----------------

Information on the various clinical symptoms and enterpathogens was available for 161--191 children. The percentage of children infected with EAEC who had more than 10 stools on the most severe day of illness was significantly higher (50%) than those who were negative for EAEC (19.8%); this percentage was highest in patients with co-infection of EAEC and rotavirus (55.6%), compared to those who were infected with EAEC only (42.9%), rotavirus only (18.8%) or patients who tested negative for both pathogens (21.3%) (Table [2](#Tab2){ref-type="table"}). In logistic regression model, co-infection of rotavirus with EAEC was associated with a 7-fold increased probability of having more than 10 stools on the most severe day of illness (P = 0.015), than children who were negative for both pathogens. Infection with *Shigella* was also strongly associated with having more than 10 stools on the most severe day of illness (Table [3](#Tab3){ref-type="table"}).Table 2**Clinical symptoms in children with gastroenteritis, by presence of enteropathogens** ^**a**^**\>10 stools/day n/total (%)Vomiting n/total (%)Fever \>39°C n/total (%)**DEC positive single infection4/14 (28.6%)13/16 (81.3%)9/15 (60.0%)DEC positive mixed infection6/22 (27.3%)18/22 (81.8%)12/21 (57.1%)DEC negative23/121 (19.0%)113/131 (86.3%)78/128 (60.9%)DEC and rotavirus positive6/21 (28.6%)19/21 (90.5%)11/20 (55.5%)DEC negative and rotavirus positive14/68 (20.6%)65/72 (90.3%)40/71 (56.3%)DEC positive and rotavirus negative5/18 (27.8%)15/20 (75.0%)12/19 (63.2%)DEC and rotavirus negative14/64 (21.9%)59/71 (83.1%)40/68 (58.8%)EAEC positive8/16 (50%)\*13/18 (72.2%)\*\*6/17 (35.3%)\*EAEC negative32/162 (19.8%)151/173 (87.3%)102/167 (61.1%)EAEC and rotavirus positive5/9 (55.6%)\*8/9 (88.9%)\*2/9 (22.2%)EAEC negative and rotavirus positive15/80 (18.8%)76/84 (90.5%)49/82 (59.8%)EAEC positive and rotavirus negative3/7 (42.9%)5/9 (55.6%)4/8 (50.0%)EAEC and rotavirus negative16/75 (21.3%)69/82 (84.1%)48/79 (60.8%)Atypical EPEC positive3/19 (15.8%)17/19 (85.5%)14/18 (77.8%)\*\*Atypical EPEC negative37/159 (23.3%)147/172 (85.5%)94/166 (56.6%)Atypical EPEC and rotavirus positive1/10 (10.0%)9/10 (90.0%)8/9 (88.9%)Atypical EPEC negative & rotavirus positive19/79 (24.1%)75/86 (90.4%)43/82 (52.4%)Atypical EPEC positive & rotavirus negative2/9 (22.2%)8/9 (88.9%)6/9 (66.7%)Atypical EPEC and rotavirus negative17/73 (23.3%)66/82 (80.5%)46/78 (59.0%)\*Pv \<0.05 \*\*Pv \<0.1.^**a**^This analysis in based on the total number of children with complete information on the various clinical symptoms, and detection of enteric pathogens. The total number in each category is indicated in the table.Table 3**The association between EAEC and rotavirus co-infection with having more than 10 stools in the most severe day of illnessAdjusted OR (95% CI)\*Pv**EAEC and rotavirus positive7.00 (1.45-33.71)0.015EAEC negative and rotavirus positive1.56 (0.60-4.07)0.35EAEC positive and rotavirus negative3.84 (0.66-22.2)0.13EAEC and rotavirus negativeReference*Shigella* positive12.49 (2.59-61.15)0.002*Shigella* negativeReference\*The variables entered in the analysis at step 1 were EAEC/rotavirus, *Shigella*, *Salmonella* and *Campylobacter*. The final model included only EAEC/rotavirus and *Shigella*.

It was also observed that children infected with EAEC were significantly less likely to have high fever (\>39°C) compared to EAEC-negative children (35.3% vs. 61.1%) (Table [2](#Tab2){ref-type="table"}). Infection with any DEC (single or mixed infections), was not associated with the above symptoms, neither was atypical EPEC.

Characterization of the EAEC isolates {#Sec13}
-------------------------------------

Among all 27 EAEC isolates tested for antibiotic resistance, 96% were resistant to CL, 85% CFM and KF, and 78% showed resistance AMP. Lower resistance rates were found to the antibiotics AMC (44.5%), SXT and T (33.5%), and C and NA (18.5%). A low (3--9.5%) resistance rate was found to CIP, CRO and CXM, while no isolate was resistant to GM or NOR.

O-typing of EAEC isolates showed two clusters with the same O and H antigens; O15:H18 and O175:H31. The remaining isolates belonged to different clusters. Although the same O86 antigen was found on two isolates, these differed in their H antigens (Table [4](#Tab4){ref-type="table"}).Table 4**Distribution of different serotypes among the identified EAEC isolates** ^**a**^**SerotypeEAEC isolateO antigenH antigen**S1ND^b^H10S2O3H30S3O3H2S4O39H21S5O7H4S6O73NDS7O86NDS8O86H30S9O92H33S10O103H43S11O103H2S12O104NDS13O111H21S14O111H21S15O128H10S16O130H27S17O15H18S18O15H18S19O15H18S20O15H18S21O15H18S22O153H30S23O153NDS24O153H18S25O168H4S26O175H31S27O175H31^a^This analysis is based on 27 EAEC isolated that were identified among all 307 samples that were tested for DEC.^b^Not defined.

Pulsed-field gel electrophoresis (PFGE) was applied to assess clonal-relatedness between the isolates having the serotype O15:H18 (isolates S17-S20) or O175:H31 (S26 and S27) (Figure [1](#Fig1){ref-type="fig"}). The two isolates within the cluster of O175:H31 were closely related, as there was a difference in one band between the PFGE pulsotypes of these two isolates. Within O15:H18 cluster, the two isolates S17 and S18 were also closely related, while S19 and S20 were different in a few bands and therefore less closely related. The clonal relatedness of the isolates in relation to their PFGE pulsotype patterns was further assessed with the available antibiotic resistance data. Isolates with serotype O175:H31 had a similar but not identical resistance profile to the majority of antibiotics tested (Table [5](#Tab5){ref-type="table"}). A somewhat similar pattern of antibiotic resistance was also seen among the isolates with the serotype O15:H18.Figure 1**A dendrogram displaying PFGE profiles of the examined EAEC isolates.**Table 5**Antibiogram of the EAEC isolates with the same serotypesEAEC isolatesSerotypeAMC 30 μgAMP 10 μgCFM 5 μgCRO 30 μgCXM 30 μgCL 30 μgKF 30 μgC 30 μgCIP 5 μgGM 10 μgNA 30 μgNOR 10 μgSXT 25 μgT 30 μg**S17O15:H18I^a^R^b^RIS^c^RRRSSSISSS18O15:H18IRISSSRSSSSSRSS19O15:H18IRRISRRRSSSSRSS20O15:H18RRRISRRSSISSSSS26O175:H31IRISSRRSSSSSRRS27O175:H31ISRSIRRSSSSSSRThe resistance to antibiotics was examined as described in [Methods](#Sec2){ref-type="sec"}.^a^Intermediate.^b^Resistant.^c^Sensitive.

Discussion {#Sec14}
==========

A newly developed practical and simple mPCR method \[[@CR13]\] was used for the detection of 4 DEC categories (EAEC, ETEC, EPEC and EHEC) in stool specimens from children hospitalized with acute diarrhea. We demonstrated that these 4 DEC pathotypes were common (19.2%) in young children hospitalized with diarrhea in a high-income country. The investigated DECs were found as a sole pathogen in 10% of patients thus indicating that the addition of molecular-diagnosis for DEC identified a substantial portion of enteric pathogens in stool samples of diarrhea patients who tested negative for routinely screened pathogens. EAEC and atypical EPEC were the most prevalent DEC pathotypes. Our findings are in agreement with previous reports from Europe and the United States, showing high prevalence of DEC in patients with sporadic diarrhea \[[@CR3],[@CR5],[@CR17]\].

Notably, EAEC and atypical EPEC comprised the majority of DEC in this study. EAEC is traditionally linked with increased risk of persistent diarrhea \[[@CR18]-[@CR21]\], but it also can cause acute diarrhea among different sub-populations \[[@CR3],[@CR5],[@CR21],[@CR22]\]. EPEC is associated with persistent diarrhea in developing countries, and might be implicated in the etiology of diarrhea in industrialized countries, and atypical EPEC is more prevalent than typical EPEC \[[@CR23]-[@CR28]\]. These findings appraise the need for considering antibiotic therapy in DECs-associated acute diarrhea.

A high percentage of EAEC and EPEC infections were mixed with other enteropathogens, mostly with rotavirus. Interestingly, we found that patients co-infected with EAEC and rotavirus had a significant 7-fold increased likelihood of having a large number of watery stools (\>10) on the most severe day of illness, compared to children who did not harbor these pathogens. Such an intriguing observation was not found with mixed rotavirus and EPEC infection or with rotavirus and all combined DEC categories. This supports the notion that the observed relationship between mixed rotavirus-EAEC infection and a more severe illness is likely the result of synergy between these two pathogens. One possible explanation is the difference in pathogenesis of illness induced by rotavirus and EAEC. It has been shown that adhesion of different EAEC strains occurs at different locations in the intestine \[[@CR29]\], while rotavirus infects enterocytes near the tips of villi of the small intestine \[[@CR30]\]. EAEC bacteria adhere to the intestinal mucosa in an aggregative manner forming a characteristic stacked-brick pattern; toxin release then elicits an inflammatory response, mucosal toxicity and intestinal secretion \[[@CR31]\]. EAEC toxins can be destructive to the tips and sides of villi and enterocytes \[[@CR32]\]. Rotavirus on the other hand primarily causes malabsorptive diarrhea through destruction of absorptive enterocytes and down-regulation of absorptive enzymes \[[@CR30]\]. Therefore, we postulate that during EAEC and rotavirus co-infection, both pathogens act simultaneously on the human gut, possibly at different sites, thus resulting in more extensive enteritis, and severe illness. Our unique observation is supported by *in vitro* and animal studies \[[@CR33]\] as well as epidemiological studies \[[@CR34],[@CR35]\] indicating the existence of synergy between rotavirus and *E. coli*, or other pathogens. It is also possible that one infection, either EAEC or rotavirus, creates favorable conditions in the gut for the other infection.

PFGE, O-typing and antibiotic susceptibility pattern were studied in concert with examining clonality of EAEC, which was the dominant DEC in our group of hospitalized children. Using PFGE, genotypic characterization of EAEC isolates of the same serotype showed clusters of isolates having the same pulsotype. In one cluster, two isolates with the serotype O15:H18 showed a difference in only one fragment, which based on generally accepted criteria \[[@CR36]\] the isolates would be considered as closely related. Moreover, these isolates had a similar pattern of antibiotic resistance, confirming their close clonal relatedness. Two additional O15:H18 isolates, differing in only a few bands in their pulsotypes, which had a similar pattern of antibiotic resistance, might also be related. The O175:H31 serotype isolates had also similar pulsotypes indicating that these isolates are closely related. Since the children with these isolates were hospitalized in different locations and years, this may suggest that the EAEC strain has been circulating in different regions and time points in Israel.

The multiplex PCR applied in this study had been developed for identification of the main prevalent DEC, i.e. ETEC, EAEC, EHEC, and EPEC. We did not examine the presence of DAEC and EIEC. Therefore, our results may underestimate the prevalence of DEC in acute severe diarrhea in young children. Additionally, the clinical information was lacking in about one third of the patients. However, despite these limitations, our study adds new knowledge regarding the importance of detecting DECs in severe pediatric diarrhea in non-epidemic-conditions in high-income countries.

Conclusions {#Sec15}
===========

With the application of a newly developed practical and simple mPCR method to detect four main DECs categories we demonstrated that EAEC and atypical EPEC are common in children with severe sporadic diarrhea in a high-income country, and that mixed infections with rotavirus and EAEC may influence the severity of the disease.

**Competing interests**

The authors declare that they have no competing interests.

**Authors' contributions**

JT: Conceived the study, carried out the molecular genetic studies, and was responsible for writing the manuscript from its initial version to the end. EK: Significant contribution in the clinical aspects of the study and collection of the data and stool samples. UR: Significant contribution in the clinical aspects of the study and collection of the data and stool samples. AB: Carried out the microbiological studies. S-RV: Carried out the molecular genetic studies. AN: Carried out the O-typing. AR: Carried out the molecular genetic studies. LV: Carried out the molecular genetic studies. ME: Very significant contribution in the clinical aspects of the study and collection of the data and stool samples. DC: Conceived the study, participated in its design and coordination of the manuscript. KM: Conceived the study, participated in the studies and its design, data analysis and writing the manuscript. All authors have read and approved the final manuscript.

The molecular analyses by mPCRs were supported by a kind grant from KVVS (Kungliga Vetenskaps- och Vitterhetssamhället) and the clinical and laboratory follow up were supported in part by a grant from Nuclear Threat Initiative, Washington DC in frame of the Middle East Consortium for Infectious Diseases Surveillance. The authors would like to thank Dr. Matilda Nicklasson for the scientific advice in part of the molecular analyses of the EAEC isolates, Mr. Premkumar Sidhuraj for confirming the mPCR results, and Mrs. Sophy Goren in data management.
